Cofactor Genomics, NCI to Demonstrate Clinical Utility of Paragon Assay
Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor immune-profiling assay requiring only two FFPE [...]